baber/WOPTO huggingface dataset:
Patent NZ-574850-A (NZ)
Title: Advanced emergency geographical information system
Inventor: GRANGE JEFF T
IPC: G01C21/36
Filed: 2007-08-10
Abstract: A method and a system for integrating multiple spatial emergency data, multiple non-spatial emergency data or both multiple spatial emergency data and multiple non-spatial emergency data into a real-time geographic information system for analysing emergency data are disclosed. The system comprises one or more emergency services vehicles. Each emergency services vehicle is adapted to provide one or more spatial data sets and/or one or more non-spatial data sets. The system further comprises one or more user's console communicatively coupled to the one or more emergency services vehicle via a data converter in which the one or more spatial data sets and the one or more non spatial data sets when received are converted into a mark-up language; a display electrically connected to the one or more user's console, including a user selectable region geographic map on which the converted data sets may be overlaid; one or more trauma activation alerts communicatively coupled to the one or more user's console; and a multi-way communication means electrically connected to the one or more user's console. Each emergency services vehicle can be equipped with a geographic information system transceiver selected from the group consisting of an automatic vehicle location system, an integrated global positioning system and a portable global positioning system transceiver; and the trauma activation alerts are selected arrival of the trauma victim, estimated arrival time, routing problems and traffic delays.
Patent NZ-575551-A (NZ)
Title: A pram with a removeable sub-frame
Inventor: DRIESSEN FRANCISCUS JOHANNUS CORNELIS
IPC: B60N2/28
Filed: 2007-09-14
Abstract: A pram comprises a collapsible undercarriage 2 provided with moving means, and a sub-frame which is releasable from the undercarriage and which is provided with means for supporting a child. The sub-frame is provided with a tiltable push bar 40 and is reversible relative to the undercarriage 2.
Patent NZ-583361-A (NZ)
Title: Peptides for desensibilization against allergens
Inventor: LARCHE MARK
IPC: A61K39/35
Filed: 2008-08-15
Abstract: Disclosed are peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.
Patent NZ-583546-A (NZ)
Title: Sliding window or door with multiple panes and a sill and a head formed of parts snap-fitted together
Inventor: LANGNER ROBERT CHARLES
IPC: E06B3/46
Filed: 2008-08-29
Abstract: Disclosed is a sliding window or door (10) which aims to prevent water leakage. The window or door has at least two panes (23, 24) which extend in a generally vertical plane and at least one of which is movable generally horizontally. A sill (11) including a channel (17) extends generally horizontally and within it bottom edge portions of each of the at least two panes are received. A dividing member (20) is located the channel which extends between the at least two panes. The dividing member extends either in contact with or in close facing relationship with the bottom edge portions of the at least two panes. A head (12) receives the top edge portions of each of the at least two panes in a manner similar to the sill, the head being formed of at least two parts which are snap fitted together.
Patent NZ-583629-A (NZ)
Title: An external power point arrangement
Inventor: NG WILSON
IPC: H01R24/76
Filed: 2008-12-10
Abstract: A pre-wired electrical connection arrangement comprises a power outlet 7.052 having a first power input connector 7.058 and a first power outlet connector, and an intermediate connection support 7.002 having a second power input connector 7.010 adapted to be connected to a pre-existing power outlet. The intermediate connection support 7.002 includes a cable 7.012 and a second power outlet connector 7.014. The second power outlet connector 7.014 is adapted to be connected to the first power input connector 7.058. (62) Divided Out of 573490
Patent NZ-586945-A (NZ)
Title: Electrode with current lead embedded in a recess filled only with conductive particles
Inventor: HOP JORUND
IPC: C25C3/08
Filed: 2009-02-02
Abstract: An electrode is disclosed for use in an electrolysis process for production of aluminium. The electrode comprises a body (3) of calcinated carbonaceous material connected to an electrical current lead (1). The current lead (1) is embedded in a recess (2) in the carbonaceous body (3), the recess (2) being wider than the lead (1). The recess (2) is filled with an electric conductive material consisting only of conductive particles (4).
Patent NZ-588927-A (NZ)
Title: Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
Inventor: KONDA VEERA
IPC: C07C49/00
Filed: 2009-04-02
Abstract: Disclosed is a use of a compound selected from the group consisting of (+)-(4R,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4- methylpentanoyl)cyclopent-2-en-1-one, (-)-(4S,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, (+)-(4R,5S)-3,4-dihydroxy-5-(3-methylbutyl)-4-(4-methylpentanoyl)-2-(3-methylpropanoyl)cyclopent-2-en-1-one, (-)-(4S,5s)-3,4-dihydroxy-5-(3-methylbutyl)-4-(4-methylpentanoyl)-2-(3-methylpropanoyl)cyclopent-2-en-1-one, (+)-(4R,5S)-3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one and (+)-(4R,55)-3,4-dihydroxy-5-(3-methylbutyl)-4-(4-methylpentanoyl)-2-petanoylcyclopent-2-en-1 -one in the manufacture of a medicament for treating a disease or disorders responsive to an increase in vascular elasticity or dilation in a subject in need thereof, wherein said compound increases vascular elasticity or dilation.
Patent NZ-589344-A (NZ)
Title: Wind turbine comprising a main bearing and method for replacement of the main bearing using tappets or shims
Inventor: STIESDAL HENRIK
IPC: F03D11/00
Filed: 2009-07-01
Abstract: Disclosed is a wind turbine and a method for simplifying the replacement of the main bearing. The wind turbine comprises a rotatable main shaft having a centre axis and being at least indirectly connected to a wind turbine rotor of the wind turbine and at least one main bearing supporting the rotatable main shaft at least indirectly against a first stationary shaft of the wind turbine. Fastening means of bolt holes, bolts and/or at least one shim are provided for fastening the wind turbine rotor to the first or a second stationary part of the wind turbine during replacement of the at least one main bearing. Tappet means are provided on the rotatable main shaft which are able to act on the at least one main bearing and permit a movement of the at least one main bearing relative to the first stationary part in the direction of the centre axis. While replacing the at least one main bearing, the rotatable main shaft and the at least one main bearing are moved together relatively to the first stationary part in the direction of the centre axis.
Patent NZ-591642-A (NZ)
Title: Safety apparatus
Inventor: FOUNTAIN PETER DAVID
IPC: A42B3/16
Filed: 2009-08-19
Abstract: 591642 A combined ear and eye protection apparatus (100) with an eye protector assembly (110) and two earmuff style ear protectors (120, 125) is disclosed. An eye protector forms a barrier for protecting a wearer's eyes and includes arms (130, 135 - not shown) for permitting positioning on a wearer's head (105). The ear protectors have a mounting (150, 155 - not shown) located toward an upper edge of the ear protector for rotationally attaching the arms of the eye protector. The arms of the eye protector are resiliently urged inwardly to grip the wearer's head and support the apparatus in place when worn so the ear protectors can be operatively held relative to a wearer's ears so that one ear protector can cover one ear and the other ear protector can cover the other ear. The eye protector assembly can be moved rotationally relative to the ear protectors between a first position where a body of the apparatus rests on the wearer's face to provide protection to the wearer's eyes and ears and an alternative position where the body rests in a position where protection is not provided to the wearer's eyes but is provided to the wearers ears.
Patent NZ-596824-A (NZ)
Title: 17beta-ALKYL-17alpha-OXY-ESTRATRIENES
Inventor: BOHLMANN ROLF
IPC: A61K31/56
Filed: 2010-05-26
Abstract: Disclosed herein are oestratrienes of general formula (I), wherein the variables are defined in the specification, and the use thereof in in the treatment of oestrogen-dependent disorders. Exemplary compounds include: 11?-fluoro-17?-methyl-7?-[5-[(2R)-2-(6,6,7,7,7-pentafluoroheptyl)-1-pyrrolidinyl]pentyl]oestra-1,3,5(10)-triene-3,17?-diol; and 11?-fluoro-17?-methyl-7?-[5-[methyl(8,8,9,9,9-pentafluorononyl)amino]pentyl]oestra- 1,3,5(10)-triene-3,17?-diol.
Patent NZ-596951-A (NZ)
Title: Novel fetal markers for prenatal diagnosis and monitoring
Inventor: LO YUK MING DENNIS
IPC: C12Q1/68
Filed: 2007-05-03
Abstract: Patent No. 596951 Disclosed is a method for detecting or monitoring a pregnancy-associated disorder in a woman pregnant with a fetus, comprising the steps of: (a) determining the methylation status of a CpG-containing genomic sequence in a biological sample from the woman, wherein the sample is whole blood, serum, plasma, urine, or saliva, wherein the genomic sequence from the fetus and the genomic sequence from the woman are differentially methylated, thereby distinguishing the genomic sequence from the woman and the genomic sequence from the fetus in the sample, wherein the genomic sequence is at least 15 nucleotides in length, comprising at least one cytosine, and is within a region on chromosome 21, and wherein the region consists of (1) a genomic locus of Holocarboxylase Synthetase (HLCS);and (2) a DNA sequence of no more than 10 kb upstream and/or downstream from the locus; (b) determining the level of the genomic sequence from the fetus; and (c) comparing the level of the genomic sequence from the fetus with a standard control, wherein an increase from the standard control indicates the presence or progression of a pregnancy-associated disorder.
Patent NZ-598685-A (NZ)
Title: Heterocylcic derivatives as inhibitors of glutaminyl cyclase
Inventor: HEISER ULRICH
IPC: A61K31/4184
Filed: 2010-09-13
Abstract: 598685 Disclosed herein are pyrrolidine derivatives of formula (I), wherein X, Y, Z, R1, R2 and R3 are as defined herein, as inhibitors of glutaminyl cyclase, and the use thereof in the treatment of rheumatoid arthritis, atherosclerosis, pancreatitis and restenosis. Further disclosed is a pharmaceutical composition comprising a pyrrolidine derivative of formula (I) which additionally comprises at least one compound, selected from the group consisting of neuroprotectants, antiparkinsonian drugs, amyloid protein deposition inhibitors, beta amyloid synthesis inhibitors, antidepressants, anxiolytic drugs, antipsychotic drugs and anti-multiple sclerosis drugs. Specific embodiments of the compound include: 5-tert-butyl-1-(1H-benzo[d]imidazol-5-yl)imidazolidin-2-one, 1-(1H-benzo[d]imidazol-5-yl)-5-(2-chlorophenyl)imidazolidin-2-one, (S)-4-(1H-benzo[d]imidazol-6-yl)-5-(4-propoxyphenyl)morpholin-3-one, and (8)-1-(1H-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one,
Patent NZ-600444-A (NZ)
Title: Process for changing a spent anode and support and system for the temporary storage of such a spent anode
Inventor: FAURE MAXIME
IPC: C25C7/06
Filed: 2010-10-19
Abstract: Disclosed is a process for changing a spent anode from an aluminum electrolysis cell to reduce toxic fluroinated gas discharges. The method involves pouring an extinguishing powder (5) onto a used anode that has been removed from an electrolysis bath that is placed on a holder (1), for covering said anode, so as to limit the emission of fluorinated gases by means of the anode. The holder may include a temporary tank that is pre-filled with powder and provided with an opening for pouring the powder onto the anode that is placed on the holder. The powder (5) is selected from the group including alumina, substances comprising aluminum fluoride and/or sodium fluoride, such as cryolite, sand or a mixture of these.
Patent NZ-603143-A (NZ)
Title: Membrane cleaning with pulsed airlift pump
Inventor: ZHA FUFANG
IPC: B01F3/04
Filed: 2012-10-19
Abstract: 603143 An assembly including an immersed membrane module (5) for the treatment of wastewater. The immersed membrane module (5) has a lower potting head (7), and one or more devices (11) located below or in combination with the lower potting head (7) for providing gas bubbles in a liquid (19) in which the membrane module (5) is immersed. The one or more devices (11) each include a housing defining a gas collection chamber (12) and having an opening below the gas collection chamber allowing communication between the inside of the collection chamber (12) and the outside of the gas collection chamber (12). The devices further have a gas transfer compartment having a first opening in fluid communication with the gas collection chamber (12) and a second opening (17) in fluid communication with the outside of the gas collection chamber (12). The gas collection chamber (12) is adapted to hold a pocket of the gas above an interface between the gas pocket and the liquid (19), the interface having a variable elevation ranging from at least a lower boundary of the first opening in the gas transfer compartment to an upper boundary of the low point of the gas transfer compartment.
Patent NZ-603463-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: HANSEN TODD M
IPC: A61K35/00
Filed: 2010-11-22
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. In one embodiment the compound is N-(4-{ [4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzoyl]sulfamoyl} -2-nitrophenyl)-4-cyanopiperidine-1-carboxamide.
Patent NZ-615608-A (NZ)
Title: Systems and methods of twisting and heat-setting yarn, and apparatus for twisting yarn and heat-setting yarn
Inventor: RITTENHOUSE RONNIE
IPC: D02G3/28
Filed: 2009-07-16
Abstract: An apparatus 10 for twisting yarn and heat-setting twisted yarn, comprises a high speed twisting system 12 for spinning at least two yarns to form a twisted yarn at a twisting speed of about 10,000 to 100,000 rpm, a tension reducing system 14 for reducing the tension in the twisted yarn, an accumulating system 16 for accumulating the twisted yarn, and a heat-setting system 18 for heat-setting the twisted yarn to form a heat-set twisted yarn. When the high speed twisting system 12 is stopped, the operation of the heat-setting system 18 continues uninterrupted.
Patent NZ-616806-A (NZ)
Title: Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
Inventor: BHAGWAT SACHIN SUBHASH
IPC: A61P31/04
Filed: 2011-10-04
Abstract: Disclosed herein are pharmaceutical compositions comprising a pharmaceutically effective amount of: (a) sulbactam or a pharmaceutically acceptable salt thereof, and (b) trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo-[3.2.1]-octane-2-carboxamide or a pharmaceutically acceptable salt thereof. Also disclosed is the use of these compositions in the manufacture of a medicament for the treatment of bacterial infection.
Patent NZ-631197-A (NZ)
Title: Anti sez6 antibodies and methods of use
Inventor: DYLLA SCOTT J
IPC: C07K16/28
Filed: 2013-02-22
Abstract: Disclosed is an anti-SEZ6 antibody or an immunoreactive fragment thereof, and the use of such in the manufacture of a medicament for treating cancer and reducing the frequency of tumor initiating cells.
Patent NZ-706262-A (NZ)
Title: Heated aerosol-generating device and method for generating aerosol with consistent properties
Inventor: KUCZAJ ARKADIUSZ
IPC: A24F47/00
Filed: 2013-12-17
Abstract: There is provided a method of controlling aerosol production in an aerosol-generating device, the device comprising: a heater comprising at least one heating element configured to heat an aerosol-forming substrate; and a power source for providing power to the heating element, comprising the steps of: controlling the power provided to the heating element such that in a first phase power is provided such that the temperature of the heating element increases from an initial temperature to a first temperature, in a second phase power is provided such that the temperature of the heating element drops below the first temperature and in a third phase power is provided such that the temperature of the heating element increases again. Increasing the temperature of the heating element during a final phase of the heating process reduces or prevents the reduction in aerosol delivery over time.
Patent NZ-708179-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C13K1/02
Filed: 2010-02-11
Abstract: Biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) are processed to produce useful products, such as fuels. For example, systems are described that can use feedstock materials, such as cellulosic and/or lignocellulosic materials and/or starchy materials, to produce a product or intermediate, e.g., energy, a food, a fuel, or a material.
Patent NZ-710468-A (NZ)
Title: Sustained-release lipid pre-concentrate of gnrh analogues and pharmaceutical composition comprising the same
Inventor: YU HA NA
IPC: A61K47/30
Filed: 2013-12-27
Abstract: Disclosed is a pharmaceutical composition, comprising: a) at least one sorbitan unsaturated fatty acid ester having a polar head with at least two or more -OH (hydroxyl) groups; b) at least one phospholipid; c) at least one liquid crystal hardener which is free of an ionizable group and has a triacyl group with 15 to 40 carbon atoms or a carbon ring structure in a hydrophobic moiety; and d) at least one GnRH (gonadotropin-releasing hormone) analogue as a pharmacologically active substance, wherein said lipid pre-concentrate exists as a liquid phase in absence of aqueous fluid and forms into a liquid crystal in presence of aqueous fluid. The pharmaceutical composition is configured to enhance the sustained release of the pharmacologically active substance GnRH analogue.
Patent NZ-721552-A (NZ)
Title: Tool and method for aligning a tissue plane for microtomy
Inventor: HEMMINGS KURT
IPC: A61B17/3205
Filed: 2014-12-23
Abstract: A tool and a method are provided, for applying a correction on a resection margin of a tissue block, in order to align the resection margin with the cutting plane of a microtome. The correction is determined using an embedding block having been cut by the microtome. The tool comprises a base, a chuck receiver, a positioning assembly comprising a flat surface and a bi-axial pivoting assembly operatively connected to one of the chuck receiver and the positioning assembly. The positioning assembly and the chuck receiver are movable one relative to the other for pressing the embedding block between said flat surface of the positioning assembly and the top surface of the chuck, for tilting the bi-axial pivoting assembly according to a compensating angle indicative of the correction to make. The problems this device address can be considered to be to get useful samples out of a tissue section which may or may not be a good initial cut and shape, so the device facilitates using the sample already cut and reduces the need to take multiple samples from the subject or patient.
Patent NZ-725067-A (NZ)
Title: Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer
Inventor: OKABE HIROYUKI
IPC: A61P35/00
Filed: 2015-04-03
Abstract: In order to provide a novel cancer treatment method using an FTD/TPI combination drug that exhibits an outstanding anti-tumor effect and has few side effects, the present invention provides an anti-tumor drug that is characterized in that an FTD/TPI combination drug and an anti-tumor platinum complex are administered in combination.
Patent NZ-727233-A (NZ)
Title: Stabilized oxymetazoline formulations and their uses
Inventor: SARPOTDAR PRAMOD
IPC: A61K9/00
Filed: 2015-06-11
Abstract: The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.
Patent NZ-728874-A (NZ)
Title: Anti-pd-1 monoclonal antibody and obtaining method therefor
Inventor: ZHOU HAIPING
IPC: G01N33/577
Filed: 2015-10-13
Abstract: The present invention relates to the technical field of antibody engineering. Provided are a full human anti-PD-1 monoclonal antibody, a preparation method therefor, and uses thereof. Anti-PD-1 monoclonal antibodies are obtained from a fully synthetic antibody library by means of screening, and then light-chain CDR1-3-region and heavy-chain CDR1-3-region mutation construction libraries of the obtained antibody are screened in sequence by means of an affinity maturation technology to obtain a high-affinity anti-PD-1 antibody. The antibody can be used for treating tumors, inflammations, and autoimmune diseases. In a particular embodiment the anti-PD-1 monoclonal antibody comprises a CDR combination consisting of: LCDR1: RASQSVSNYLD, LCDR2: DASTRAT, LCDR3: QQNMQLPLT; HCDR1: SNYGMH, HCDR2: VIWYDSSRK, and HCDR3: TAVYYCATNNDYW.
Patent NZ-729129-A (NZ)
Title: Monitoring systems and methods
Inventor: FORSTER-KNIGHT ANDREW
IPC: G01F23/00
Filed: 2015-09-03
Abstract: A monitoring system for an access chamber to a pipe network. The system comprises at least one sensor for determining a fluid condition associated with fluid in a conduit of the pipe network and at least one threshold level indicator for determining a threshold fluid level in the access chamber, the at least one threshold level indicator being associated with the at least one sensor. The system further comprises a controller for receiving output signals from the at least one sensor and the at least one threshold level indicator and for controlling supply of power to the at least one sensor and a wireless transceiver in communication with the controller to allow the controller to communicate with a remote server over a communications network. The controller is arranged to supply power to the at least one sensor in response to receiving an output signal from the at least one threshold level indicator indicative of the fluid level having exceeded the threshold fluid level.